Accelerating Research and Development of Next Generation Vaccines against Malaria – a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support basic research, discovery, and/or preclinical development of highly efficacious vaccines for malaria and potentially…
View details →